top of page
Our Team
We are passionate about changing cancer outcomes
We have been working to improve cancer treatment through advanced diagnostics over the last 10 years. In our most recent clinical study our IVD was able to determine whether or not patients were responding completely, in part, or not all to their chemotherapy.
Our beginning
SatyaDx was founded by Sri Mohan, PhD a professor from University of New England and Susan Miesfeldt, MD, a medical oncologist from Maine Health. Over the last 10 years they have not only developed the patented NOHA assay, but completed a number of clinical pilot trials demonstrating the effectiveness of NOHA.
​
Today they have added business and financial expertise to assist in the commercialization of NOHA.
​
Our Leadership Team
bottom of page